NewsGenetically engineered nanoparticle delivers dexamethasone
directly to inflamed lungs

16th June 2021by admin0
https://nfusion-tech.com/wp-content/uploads/2021/06/genetically-engineered-nanoparticle-delivers-dexamethasonedirectly-to-inflamed-lungs_60cb1a914b603.jpeg

Nanoengineers at the University of California San
Diego have developed immune cell-mimicking nanoparticles that
target inflammation in the lungs and deliver drugs directly where
they’re needed. As a proof of concept, the researchers filled the
nanoparticles with the drug dexamethasone and administered them to
mice with inflamed lung tissue. Inflammation was completely treated
in mice given the nanoparticles, at a drug concentration where
standard delivery methods did not have any efficacy.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright @2021 New Fusion All Rights Reserved

      Designed by FallingBrick